Product Information
CHILD ALLERGY (FEXO) 30 MG/5 ML is a generic product labeled by H2-Pharma LLC, priced at $0.1192 per ML under NDC 61269052794. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 18, 2014.
The Low Outlier badge above means this manufacturer's average price in the fexofenadine hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/5mL
Manufacturer
H2-Pharma LLCNDC
61269052794
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203330FDA Approved
11/18/2014
On Market Since
7/18/2022
Pharmacological Classes
Price Statistics
The NADAC for CHILD ALLERGY (FEXO) 30 MG/5 ML has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 88.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1192 per ML |
|---|---|
| All-time high | $0.1192 (Sep 30, 2026) |
| All-time low | $0.0598 (Nov 19, 2025) |
| 52-week high | $0.1192 |
| 52-week low | $0.0598 |
| Median price | $0.0640 |
| Average price | $0.0705 |
| Largest weekly change | +22.1% (May 20, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fexofenadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
H2-Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fexofenadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILD ALLERGY (FEXO) 30 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILD ALLERGY (FEXO) 30 MG/5 ML, manufactured by H2-Pharma LLC, is $0.1192 per ML (NDC 61269052794), effective Sep 30, 2026.
How has the price of CHILD ALLERGY (FEXO) 30 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILD ALLERGY (FEXO) 30 MG/5 ML has risen 88.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CHILD ALLERGY (FEXO) 30 MG/5 ML?
Since Apr 17, 2024, the NADAC for CHILD ALLERGY (FEXO) 30 MG/5 ML has ranged from a low of $0.0598 (Nov 19, 2025) to a high of $0.1192 (Sep 30, 2026), with a median of $0.0640 per ML.
Are there cheaper alternatives to CHILD ALLERGY (FEXO) 30 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of CHILD ALLERGY (FEXO) 30 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHILD ALLERGY (FEXO) 30 MG/5 ML?
CHILD ALLERGY (FEXO) 30 MG/5 ML (NDC 61269052794) is labeled by H2-Pharma LLC, and CMS classifies it as a generic product.